相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Short Peptide-Mediated Brain-Targeted Drug Delivery with Enhanced Immunocompatibility
Juan Guan et al.
MOLECULAR PHARMACEUTICS (2019)
Peptide ligand-mediated targeted drug delivery of nanomedicines
Zhuxuan Jiang et al.
BIOMATERIALS SCIENCE (2019)
Protein corona-mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses
Limei Shen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Formation of protein corona in vivo affects drug release from temperature-sensitive liposomes
Zahraa S. Al-Ahmady et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption
Juan Guan et al.
NATURE COMMUNICATIONS (2018)
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo
Fangfang Chen et al.
NATURE NANOTECHNOLOGY (2017)
Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System
Francesco Barbero et al.
SEMINARS IN IMMUNOLOGY (2017)
Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona
Giulio Caracciolo et al.
TRENDS IN BIOTECHNOLOGY (2017)
Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's disease
Aman P. Mann et al.
NATURE COMMUNICATIONS (2017)
Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics
Nicolas Bertrand et al.
NATURE COMMUNICATIONS (2017)
Cholera Toxin Subunit B Enabled Multifunctional Glioma-Targeted Drug Delivery
Juan Guan et al.
ADVANCED HEALTHCARE MATERIALS (2017)
Endothelial LRP1 transports amyloid-beta(1-42) across the blood-brain barrier
Steffen E. Storck et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties
Arafeh Bigdeli et al.
ACS NANO (2016)
Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake
Vahid Mirshafiee et al.
BIOMATERIALS (2016)
Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier
Cristina Merino-Zamorano et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers
Susanne Schoettler et al.
NATURE NANOTECHNOLOGY (2016)
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Daniel Bobo et al.
PHARMACEUTICAL RESEARCH (2016)
Toxins and derivatives in molecular pharmaceutics: Drug delivery and targeted therapy
Changyou Zhan et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
A D-Peptide Ligand of Nicotine Acetylcholine Receptors for Brain-Targeted Drug Delivery
Xiaoli Wei et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Liposome-based glioma targeted drug delivery enabled by stable peptide ligands
Xiaoli Wei et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E
Ana Rute Neves et al.
NANOTECHNOLOGY (2015)
Mapping protein binding sites on the biomolecular corona of nanoparticles
Philip M. Kelly et al.
NATURE NANOTECHNOLOGY (2015)
A holistic approach to targeting disease with polymeric nanoparticles
Christopher J. Cheng et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?
Takahisa Kanekiyo et al.
NEURON (2014)
Phase I Study of GRN1005 in Recurrent Malignant Glioma
Jan Drappatz et al.
CLINICAL CANCER RESEARCH (2013)
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
Anna Salvati et al.
NATURE NANOTECHNOLOGY (2013)
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Stefan Tenzer et al.
NATURE NANOTECHNOLOGY (2013)
Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier
Daren Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Challenges in design and characterization of ligand-targeted drug delivery systems
Silvia Muro
JOURNAL OF CONTROLLED RELEASE (2012)
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J. Pugh et al.
NATURE (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Zhiliang Cheng et al.
SCIENCE (2012)
Targeted drug delivery to tumors: Myths, reality and possibility
You Han Bae et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Physical-Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles
Marco P. Monopoli et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier
Thorsten Pflanzner et al.
NEUROBIOLOGY OF AGING (2011)
Time Evolution of the Nanoparticle Protein Corona
Eudald Casals et al.
ACS NANO (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB)
Karsten Ulbrich et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Differential receptor-mediated drug targeting to the diseased brain
J. Rip et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones
Anja Zensi et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2
Michel Demeule et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
Martin Lundqvist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
Tommy Cedervall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's Aβ(1-42) and Aβ(25-35)
S Varadarajan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Endogenous carriers and ligands in non-immunogenic site-specific drug delivery
SP Vyas et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
分享论文
